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Impairment of delayed hypersensitivity
is a feature of advanced malignancy. Eilber
and Morton (Cancer, N.Y., 1970, 25, 362)
studied the response to D.N.C.B. in cancer
patients and concluded that an impaired
response indicated a poor prognosis.
We have investigated Mantoux and
D.N.C.B. responses in 112 patients with
solitary breast lumps and in 54 patients with
suspected gastric or colonic neoplasia. Re-
sults were assessed in relation to final
diagnosis (benign or malignant), tumour
staging and prognosis.
Patients with benign breast lumps were
nearly always D.N.C.B. positive, while
impaired responses occurred in 60% of
patients with breast cancer and haemato-
genous dissemination. Conversion from
negative to positive was associated with a
good response to treatment, whereas persis-
tent negativity implied a poor prognosis.
Patients with gastrointestinal malignancy
exhibited impairment of D.N.C.B. and
Mantoux tests compared with controls.
Positive tests indicated a better
prognosis.
Serial testing of delayed hypersensitivity
correlates with the course of the disease in
cancer patients.
GROWTH INHIBITORY EFFECT OF
PERITONEAL MACROPHAGES ON
HARDING PASSEY MELANOMA, ITS
IMPAIRMENT BY MACROPHAGE
LYSOSOME OVERLOADING. F. J.
LEJEUNE, E. BEAUMONT and Y. GARCIA.
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Repeated i.p. inoculations of irradiated
Harding-Passey melanoma cells (HPM) in-
duced an immune protection of mice against
living HPM graft. In vitro, spleen cells from
immune animals were found to produce a
strong growth inhibition of HPM. How-
ever, peritoneal macrophages taken 7 days
after immunization were less inhibitory than
controls. The spontaneous cytotoxicity of
control macrophages was recovered by
macrophages taken 31 days after immuniza-
tion. An electron microscopy study of the
macrophages showed lysosome overloading
with melanin on Day 7 and an important
clearing of lysosomes on Day 31.
Preliminary experiments showed that it
was possible to neutralize the inherent cyto-
toxicity of normal peritoneal macrophages
by feeding them with melanin in culture.
Explants and primary cultures of HPM
were found to contain a consistent amount of
macrophages filled with melanin. It is
suggested that malignant melanocytes can
neutralize macrophage cytotoxicity by over-
loading their lysosomes with melanin.
CHANGES IN GROWTH AND
ADHESION OF EHRLICH ASCITES
TUMOUR CELLS COATED WITH
TRYPSIN INHIBITOR (SOYBEAN).
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We report an attempt to inhibit tumour
growth using a non-agglutinating plant
protein. Mice injected i.p. with tumour cells
and subsequently with trypsin inhibitor
showed a 92% reduction of recoverable cells
compared with untreated controls after
8 days of tumour growth. No differences
were detected in rates of DNA synthesis in
vitro, but experiments in vivo indicated that
treated cells grew slightly faster. Trypsin
inhibitor, which binds to the cell surface, was
non-toxic to the treated cells. Scanning EM
micrographs showed that treated cells, unlike
untreated cells, adhered to internal abdomi-
nal surfaces, and treated cells also showed
increased agglutinability with concanavalin
A in vitro. These findings are generally
compatible with the possible existence of an
intrinsic protease, which becomes inhibited in
treated cells.